The screening technology examines RNA in a stool sample to detect the cancer, but this simple test is just the first of what CEO Andrew Barnell has told the 4thEst8 in the past that he hopes will be a platform of tests. Broadening this technology could be used to detect, prevent, and guide treatment of a wide variety of gastrointestinal diseases.

Only subscribers get to read this.

Hit SUBSCRIBE for freemium or paid content access.